Medisys sees benefits of diagnostics acquisition
This article was originally published in Clinica
Executive Summary
Forthcoming product launches have allowed UK company Medisys to remain upbeat about its prospects, despite its half-year losses increasing from £2.4 million ($3.4 million) to £3.1 million. For the six months ended March 2000, the company's turnover leapt 160% to £10.4 million. The majority of this increase came from the acquisition of the diagnostics business of MEDgenesis, a subsidiary of Chronimed.